DoD Peer Reviewed Cancer Research, Idea Award | W81XWH 20 PRCRP IA

FAQs: DoD Peer Reviewed Cancer Research Program (PRCRP) Idea Award (FY20)

What is the PRCRP Idea Award (FY20)?

The PRCRP Idea Award (FY20; Funding Opportunity Number W81XWH-20-PRCRP-IA) is a Department of Defense (DoD) funding opportunity intended to spark genuinely new, untested directions in cancer research. It is designed for high-risk, potentially high-reward concepts that could shift thinking in cancer biology, prevention, diagnosis, treatment, survivorship, or quality of life, particularly in ways that matter to the Military Health System (MHS).

What does the program mean by "idea-driven" or "innovative" research?

The core expectation is innovation rather than continuity. Applicants are expected to propose concepts that challenge existing paradigms, introduce new frameworks or methods, or approach longstanding problems from a truly different angle. The award is positioned as exploratory, not as support for the next logical step in an existing research trajectory.

Is this award appropriate for incremental or follow-on research?

No. The solicitation explicitly states it is not meant to fund incremental improvements, straightforward next steps of ongoing programs, or simple transfers of established models from one cancer type to another. The program is looking for bold ideas that may not yet have extensive supporting evidence.

Are preliminary data required to apply?

No. Preliminary data are not required. The solicitation also notes the award is not intended to support ongoing research already underway in the applicant's laboratory.

Could including extensive preliminary data hurt competitiveness?

It can be seen as inconsistent with the exploratory purpose of the award if the preliminary data go beyond truly serendipitous or incidental findings. The opportunity emphasizes that the aim is to generate robust preliminary data through the funded work, rather than to extend a well-developed project.

If the award is high-risk, does it still need to be scientifically rigorous?

Yes. Even though the idea can be new and untested, it cannot be vague. Applicants are expected to present a well-formulated, testable hypothesis supported by a strong scientific rationale and a sound study design.

What types of cancer research topics are considered relevant?

The opportunity is broadly interested in cancer biology, prevention, diagnosis, treatment, survivorship, and quality of life. The key is that the proposal should be genuinely innovative and clearly tied to military health realities and MHS relevance.

How important is the Military Health System (MHS) relevance requirement?

It is a defining feature of the opportunity. A competitive application needs to do more than state relevance to cancer in general; it must clearly explain why the military context matters and align with PRCRP Military Health Focus Areas and the mission of the Defense Health Program (DHP).

Who should the research be relevant to within the military community?

Proposed work should be relevant to active duty Service members, Veterans, and other military beneficiaries. The announcement also emphasizes "total mission readiness," noting that cancers or cancer risks affecting military families and other parts of the Service member support system are especially important.

What kinds of military connections are prioritized?

Priority is given to research tied to exposures, conditions, and circumstances that are unique to military service, disproportionately represented in military populations, or likely to affect force readiness. Applicants should make the military relevance explicit rather than implied.

How does the program define "total mission readiness" in this context?

The opportunity highlights that readiness is broader than individual Service members alone. It explicitly notes that cancers (or cancer risks) affecting military families and the broader support system around Service members can be especially important, reflecting an interest in outcomes that influence the overall ability of the force to operate effectively.

What is the expected payoff or outcome of an Idea Award project?

The expected payoff is the generation of robust preliminary data and early evidence that can serve as a foundation for future, larger efforts. The downstream value may include enabling subsequent projects that clarify mechanisms of cancer initiation or progression, improve patient care pathways, or address quality-of-life challenges during and after treatment in military-relevant populations.

Does this opportunity encourage research on advanced or metastatic cancer?

Yes, it points applicants toward national defense and congressional priorities in advanced disease. It references the Congressionally mandated Metastatic Cancer Task Force and encourages researchers to review and respond to its recommendations, as long as the proposed work fits within the limits of the Idea Award and aligns with FY20 PRCRP priorities.

Does referencing the Metastatic Cancer Task Force guarantee a good fit?

No. The opportunity signals receptiveness to innovative clinical or translational concepts related to advanced and recurrent cancers, but proposals still need to remain clearly "idea-driven" and not become incremental extensions of established programs.

Which agency is offering the award?

This is a discretionary research and development opportunity offered by the Department of Defense, Department of the Army, through USAMRAA (as stated in the opportunity summary).

What kind of funding instrument will be used?

The opportunity indicates awards can be funded via a grant or a cooperative agreement.

Who is eligible to apply?

Eligibility is listed as unrestricted, meaning it is open to any type of entity, subject to any additional eligibility details in the full announcement.

How many awards are expected?

The posting indicates an expected 38 awards.

What were the listed posting and closing dates for this FY20 opportunity?

The summary record lists a creation date of March 23, 2020, and an original closing date of August 27, 2020.

What is the maximum award amount (award ceiling)?

The source summary shows an award ceiling of 0, which typically means the budget limits are not provided in the summary record. Applicants are expected to rely on the full solicitation for the actual budget limitations and project period guidance rather than assuming a fixed maximum from the summary listing.

Where should applicants look for the official budget limits and project period details?

The summary indicates that applicants should consult the full solicitation for budget limits and project period guidance, since the summary record does not provide a usable award ceiling.

What is the most common mismatch the program is trying to avoid?

The program is explicitly trying to avoid funding continuity work: incremental advances, the next logical step in a known trajectory, or research that is already underway. The intent is to catalyze unconventional, creative ideas that are tightly connected to military health needs.

What makes an application competitive based on the summary description?

Strong applications are likely to take a clear intellectual risk, define a specific and testable hypothesis, lay out a credible plan to test it, and make a convincing case for why the military setting, military exposures, or military population needs make the question especially urgent or uniquely informative for improving care and readiness within the MHS.